Bibliografía
 

2.- Zuspan FP. Chronic Hipertension in pregnancy. Clin Obstet Gynecol 1984;27;854-861.

3.-Fuller Af. Schiiff y Knapp RC. Inmunity trofoblast and trofoblastic neoplasia. Clin Obstet Ginecol 1977; 20:681-687.

4.- Billington Wd. The inmunology of trophoblast. Inmunology of human reproduction.Scott JS y Jones WR. Academic press Londres 1976. Pag 81

5.- Davies AM. Epidemiology of the hypertensive disorders of pregnancy. Bull WHO 1979; 57: 373-386.

6.- Pelegri A, Romero R, Reguant M, Alisa L. Hipertensión arterial en el embarazo. Med Clinica (Barcelona) 1987; 88: 613-616.

7- Sibai BM, Anderson GD, Abdella TN, Mc Cubbin JH, Dilts PV. Eclampsia III. Neonatal outcome, growth and development. Am J Obstet Gynecol 1983; 146:307-316.

8.- Rodgers GM, Taylor RN, Roberts JM. PEE is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988;159:908-914.

9.- Lazarchick J, Stubbs TM, Romein L, Van Dorsten JP, Loadholt CB. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. AM J Obstet Gynecol 1986;154:1050-1067.

10.- Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of PEE and eclampsia in the descendants of eclamptic women. Br J Obstet Ginaecol 1986; 93: 898-908.

11.- Arngrimsson R, Björnsson S, Geirsson RT et al. Genetics and familial predisposition to eclampsia and PEE in a defined population. Br J Obstet Gynaecol 1990; 97: 762-769.

12.- Hayward C, Livingstone J, Holloway S et al. An exclusion map for PEE: assuming autosomal recessive inheritance. Am J Human Genet 1992; 50: 749-757.

13.- Ward K, Hata A, Jeunemaitre X et al. A molecular variant of angiotensinogen asociated with PEE. Nature Genetics 1993; 4: 59-61.

14.- Sibai BM. Inmunologic aspects of PEE. Clin Obstet Gynecol 1991; 34: 27-34.

15.- Redman CWG, Sargent IL. Inmunological disorders of human pregnacy. Oxford Rev Reprod Biol 1986; 8: 223-65.

16.- Leiberman JR. Vascular nature of PEE. Med Hypotheses 1989; 28: 281-286.

17.- Rote NS. The inmune response. In: Scott JR, Rote NS, eds. Inmunology of obstetrics and ginecology. Norwalk, CT: Appleton-Century-Crofts, 1985:27-32.

18.- Redman CWG. Current topic: PEE and the placenta. Placenta 1991; 12: 301-308.

19.- Hustin J, Schaaps JP. Ecocardiographic and anatomy studies of the maternotrophoblastic border durin the first trimester of pregnancy. Am J Obstet Gynecol 1987; 157: 162-168.

20.- Robertson WB, Khong TY. Pathology of the uteroplacental bed. In: Sharp F, Symonds EM, eds. Hypertension in pregnancy. Ithaca, NY: Perinatology Press, 1987:101-108.

21.- Sibai BM. Inmunologic aspect of PEE. Clin Obstet Gynecol 1991;34:27.

22.- Stirrat GM. The inmunology of hipertension in pregnancy. In: Sharp F, Symonds EM, eds. Hypertension in pregnancy. Ithaca, NY: Penitalogy Press 1987;249-254.

23.- Redman CWG. The fetal allograft. Fetal medicine Review 1990; 2: 21-25.

24.- Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220-228.

25.- Clark DA. Decidua-placenta inmunologic interactions. In: Chaouat G, de. The inmunology of the fetus. Boca Raton, FL: CRC, 1990: 161-167.

26.- Favier R. Presence of elevated serum interleukin-2 levels in pregnant women. N Engl J Med 1990; 322: 270-278.

27.- Petrucchio O. Aetiology of PEE. In: Studd J, de. Progress in obstetrics and gynaecology. Vol 1. Edinburgh: Longman Group, 1981; 51-54.

28.- Greer IA, Butterworth B, Liston WA, Johnston tensión arterial, Dawes J. Neutrophil activation in PIH: localisation to the placental bed. Proceedings VII World Congress of Hypertension in Pregnancy, Perugia, Italy, October 7-11, 1990, p 276.

29.- Harlan HD. Neutrophil-mediated vascular injury. Acta Med Scand 1987; 715: 123-129.

30.- Greer IA, Haddad NG, Dawes J, Johnstone FD, Calder AA. Neutrophil activation in pregnancy-induced hypertension. Br J Ostet Gynaecol 1989; 96: 978-987.

31.- Pelusi G, Scagliarini G, Biagi G, De Rosa V, Busacchi P. Neutrophil production of leukotriene B-4 is increased in gestacional hypertension. Proceedings VII World Congress of Hypertension in Pregnancy, Perulgia, Italy Octuber 7-11, 1990, p. 199.

32.- Jaffe EA. Endothelial cells. In: Gallin JI, Goldstein MI, Snyderman R, eds. Inflammation: basic principles and clinical corelates. New York: Raven, 1988: 559-565.

33.- Moncada S, Gryglewski R, Bunting S, Vane JR. An enzime isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-672.

34.- Palmer RMJ, Ferrige AG, Moncada . Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-532.

35.- Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65: 1-8.

36.- Lüscher TF. The endothelium, target and promotor of Hypertension? Hypertension 1990; 15; 482-491.

37.- Katusisc ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Heart Circ Phisiol 1989: 26: H33.

38.- Vanhoutte PM. Endothelium and control of vascular function. Hypertension 1989; 13: 658-664.

39.- Hathaway EN, Bonnar J. Hemostatic disorders of the pregnant woman and newborn infant. New York: Elsevier. 1987: 1-12.

40.- Redman CWG. Platelets and the begining of PEE. N England J Med 1990; 323: 478-482.

41.- Boer de K, Cate ten JW, Sturk A, Borm JJJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 95-107.

42.- Sibai BM. Medical disorders in pregnancy including hypertensive disease. Current opinion in Obstetrics an Gynecology 1991; 3: 28-35.

43.- Vanhoutte PM. Serotonergic antagonists and vascular disease. Cardiovascular Drugs and Therapy 1990: 4: 7-15.

44.- Weiner CP. The role of serotonin in the PEE-eclampsia syndrome. Cardiovascular Drugs and Therapy 1990; 4: 37-42.

45.- Weiner CP, Socol ML, Vaisrub N. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist. AM J Obstet Gynecol 1984; 149: 496-502.

46.- Dekker GA, Van Geijn HP. Ketanserin as second line antihypertensive therapy in severe PEE. In; Hypertension in Pregnancy. Cosmi EV, diRenzo gasto cardiaco, eds. Bologna, Italy: Monduzzi Editore, 1991; 513-523.

47.- Condie RG, Ogston D. Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of PEE. Br J Obstet Gynaecol 1976; 83: 938-946.

48.- Ballegeer V, Spitz B, Kieckens L, Moreau H, Asssche van A, Collen D. Predictive value of increased plasma levels of fibronectin in gestacional hypertension. AM J Obstet Gynecol 1989; 161: 432-441.

49.- Boer de K, Lencader I, Cate ten JW, Borm JJJ, Treffers PE. Placental-type plasminogen activator inhibitor in PEE. AM J Obstet Gynecol 1988; 158: 518-524.

50.- Feher J, Csomos G, Vereckei A. The chemistry of free radical reactions. In; Free radical reactions in medicine. Berlin: Springer-Verlag, 1987: 2-10.

51.- Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion, resolved and unresolved issues. Circulation 1989; 80: 1115-1124.

52.- Klebanoff SJ. Phagocytic cells: products of oxigen metabolism. In: Gallin JI, Goldstein MI, Snydermann R, eds. Inflammation: basic principles and clinical correlates. New York: Raven 1988: 391-399.

53.- Uotila J, Tuimala R, Pyykko K Erythrocyte glutathione peroxidase activity in hypertensive complications of pregnancy. Gynecol Obstet Invest 1990; 29: 259-265.

54.- Frank L, Massaro D. Oxigen toxicity. Am J Med 1980; 69: 117-124.

55.- Barrowcliffe TW, Gutteridge JMC, Dormancy TL. The effect of fatty-acid autooxidation products on blood coagulation. Tromb Haemost 1975; 33: 271-279.

56.- Wickens D, Wilkins MH, Luneyc J, Ball G, Dormandy TL. Free radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem 1981; 18: 158-167.

57.- Minakami H, Kimura K, Tamada T, Yasuda Y, Hirota. Hepatocellular lipofuscin in PEE. Asia Oceania J Obstet Gynaecol 1989; 15: 227-234.

58.- Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rodgers GM, McLaughlin MK. Lipid peroxidation in pregnancy: new perspectives on PEE. Am J Obstet Gynecol 1989; 161: 1025-1034.

59.- Sane AS, Chokshi SA, Mishra VV, Barad DP, Shah vasoconstricción, Nagpal S. Serum lipoperoxide levels in pregnancy-induced hypertension. Panminerva Med 1989;31: 119-125.

60.- Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without PEE. Clin Chim Acta 1981; 115: 155-167.

61.- Grygleswski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxinf factor. Nature 1986; 320: 454-465.

62.- Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-423.

63.- King AJ, Marsden PA, Brenner BM. Endothelin: a potent vasoactive peptide of endothelial origin. In; Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, diagnosis and management. New York: Raven, 1990: 649-652.

64.- Dekker GA, Kraayenbrink AA, Zeeman GG, Kamp van GJ. Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe PEE. Eur J Obstet Gynecol Reprod Biol 1991; 40: 215-232.

65.- Kamoi K, Sudo N, Ishibashi M, Yamaji . Plasma endothelin-1 levels in patients with pregnancy-induced hypertension. New England J Med 1990; 323: 1486-1492.

66.- Greer IA, Leask R, Hodson BA, Dawes J, Kilpatrick DC, Liston WA. Endothelin elastase, and endothelial dysfunction in PEE. Lancet 1991; 337: 558.

67.- Nucci de G, Thomas R, D’Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostaciclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797.

68.- Siabi BM. PEE-eclampsia. Current Problems in Obstetrics, Ginecology, and Fertility 1990;13: 6-16.

69.- Ueland K, Novy MJ, Peterson NM, Metcalfe J. Maternal cardiovascular dynamics: IV. The influence of gestacional age on the maternal cardiovascular response to posture and exercise. Am J Obstet Gynecol 1969; 104 (6): 856-864.

70.- Roberts JM. Pregnancy related hypertension. In: Creasy R, Renik R, eds. Maternal fetal medicine: principles and practice. Philadelphia: WB Saunders, 1984: 703-723

71.- Hays PM, Cruikshank DP, Dunn LJ. Plasma volume determination in normal and preeclamptic pregnancies. Am J Obstet Gynecol 1985; 151: 958-963.

72.- Bond AL, August P, Druzin M, Atlas SA, Sealey JE, Laragh JH. Atrial natriuretic factor in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 1112-1118..

73.- Lindheimer MD, Adrian IK. Current concepts: hypertension in pregnancy. N Engl J Med 1985; 313: 675-679.

74.- Thompson AM, Hytten FE, Billewicz WZ. The epidemiology of oedema during pregnancy. J obstet Gynaecol Br Commonw 1967; 74: 1-7.

75.- Pritchard J. Management and preeclampsia and eclampsia. Kidney Interm 1980:18;259-266.

76.- Frieedberg V, Hochuli E. Enfermedades específicas del embarazo. En: Ginecologia y Obstetricia. Käser O,Friedberg V, Ober KG, Thomsen K, Zander. Salvat Editores. Barcelona 1974: pag 390-412..

77.- Ferris TF. Toxemia e hipertensión. En Burrow GN, Ferris TE. Complicaciones médicas durante el embarazo. Mexico, Paramericana 1977, 55-93.

78.- Chesley LC, Duffus GM. PEE posture and renal function. Obstet Gynecol 1971;38: 1-5.

79.- Aarnoudse JG, Houthoff HJ, Weits J, Vellenga E, Huisjes HJ. A sindrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy: a clinical and histopathological study. Br J Obstet Gynaecol 1986; 145: 145-159.

80.- Sibai BH. The HELLP sindrome: much ado about nothing. Am J Obstet Gynecol 1990; 162: 311-316.

81.- Martin JM, Files JC, Blake PG, Normal PH, Martin RW, Hess LW, Morrison JC, Wiser WL. Plasma exchange for PEE: Postpartum use for persistenly severe PEE-eclampsia with HELLP syndrome. Am J Obstet Gynecol 1980; 55: 126-137

82.- Sibai BM, Scheneider JM, Morrison JC, Lipshitz J, Anderson GD, Shier RW, Dilts PV. The late postpartum eclampsia controversies. Obstet Ginecol 1980; 55: 74-78. 

83.- Trofatter KF, Howell ML, Greenberg CS. Use of the fibrin D-dimer in screening for coagulation abnormal in PEE. Obstet Gynecol 1989; 73:435-442.

84.-National High Blood Pressure Education Working Group. Report on high blood pressure in pregnancy (Consensus Report). Am J Obstet Gynecol 1990; 163:1691-1712.

85.- Belizan JM, Villar J, Zalazar A et al.. Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant womwn. Am J Obstet Gynecol 1983;146 (2):175-180.

88.- Dekker GA, Sibai BM. Early detection of eclampsia. Am J Obtet Gynecol 1991;165:160-172.

89.- Schiff E, Peleg E, Goldenberg M et al.. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321 (6): 351-356.

90.- Sureau C. Prevention of perinatal consequences of PEE with low-dose aspirin:Results of the Epreda trial. Eur J Obstet Gynecol Reprod Biol 1991;41:71-73.

91.- Brown MA. Editorial review: non-pharmacological management of pregnancy-induced hypertension. J Hypertens 1990;8:295-301

92.- Sibai BM, Taslimi M, Abdella TN, Brooks TF, Spinnato JA, Anderson GD. Maternal and perinatal outcome of conservative management of severe PEE in midtrimester. Am J Obstet Gynecol 1985;152:32-37.

93.- Sibai BM. Magnesium sulfate is the ideal anticonvulsant in PEE-eclampsia. Am J Obstet Gynecol 1990;162:1141-1145.

94.- Sibai BM, Spinnato JA, Watson DL. Eclampsia: IV. neurologic findings and future outcome. Am J Obstet Gynecol 1985; 152:184-192.

95.- Martin JN, Files JC, Blake PG.et al. Plasma exchange for PEE: Postpartum use for persistently severe PEE-eclampsia with HELLP syndrome. Am J Obstet Gynecol 1990;152:126-137.

96.- Sibai BM, Villar MA, Mabie BC. Acute renal failure in hypertension disorders of pregnancy: Pregnancy outcome and remote prognosis in thirty-one consecutive cases. Am J Obstet Gynecol 1990;162:777-783.

97.- Manas KJ, Welsh JD, Rankin RA, Miller DD. Hepatic hemorrhage without rupture in PEE. N Engl J Med. 1985:312(7);424-426.

98.- Neerhof MG, Zelman W, Sullivan T, Hepatic rupture in pregnancy: A review. Obstet Gynecol Surv 1989; 44 (6):407-409.

99.- Marx GF. Cardiopulmonary resuscitation of late-pregnant women. Anesth 1982;56(2);156-161.

100.- Katz VL, Dotters DJ, Droegemueller W. Perimortem cesaream delivery. Obstet Gynecol 1986;68(4):571-576.